SynapCell Alternatives & Competitors
12 companies similar to SynapCell — Evaluate your most effective drug candidates in vivo using objective & translati...
Companies similar to SynapCell
Neurolixis
New treatments for central nervous system disorders
Ceretype Neuromedicine, Inc.
A groundbreaking biomarker engine for neurologic and psychiatric disease
Monument Therapeutics
Bringing Precision Medicine to Neuroscience Drug Development
ONCOCROSS Co., Ltd.
AI, drug discovery development, biotechnology, indication expansion, rare disease, intract...
Rival Readout
Competing with SynapCell? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Acadia Pharmaceuticals
Acadia is trailblazing breakthroughs in neuroscience to elevate life.
UCB
We’re #TeamUCB, a global biopharmaceutical company. 💙 Inspired by patients 🔬 Driven by s...
Accure Therapeutics
R&D pharma dedicated to developing innovative medicines to treat patients suffering from C...
Aliada Therapeutics
Beyond boundaries: Crossing the blood-brain barrier to create the next generation of centr...
Novoron Bioscience
Pioneering lipoprotein-receptor drug development to repair damage and degeneration to the...
TheraIndx Lifesciences Pvt.Ltd.
Turning hits into IND-ready therapies — integrated preclinical science that speeds your pa...
NeuCyte
Decoding CNS Drug Discovery with SynFire® iP
AGY Therapeutics
Pioneering breakthrough treatments for central nervous system diseases through innovative...
About SynapCell
SynapCell is a biotechnology company founded in 2005, specializing in drug efficacy evaluation at the preclinical stage using EEG-based methods. Their innovative approach provides drug developers with quantitative and unbiased endpoints through longitudinal monitoring of drug effects on translational models, mirroring...
Drug Efficacy Testing, Collaborative Projects, Preclinical EEG Lab Services, EEG Biomarker Analysis, Model Exploration
Pharmaceutical Companies, Biotechnology Firms, Neuroscience Researchers, Drug Discovery Teams, Academia in CNS Research
CNS Drug Development, EEG Biomarkers, Neuroscience, Preclinical Evaluation, Drug Discovery Solutions, Central Nervous System, Biomarker Identification, Pharmacodynamics, Translational Models, Pharmaco-EEG, Epilepsy, Parkinson's Disease, Essential Tremors, Schizophrenia, Neural Network
B2B, DaaS, Platform
Service Fee, Project Based, Retainer
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around SynapCell: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at SynapCell on 11 Jun 2025. The 12 companies listed here were last checked between 26 Jul 2024 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.